{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T20:56:34Z","timestamp":1773089794390,"version":"3.50.1"},"reference-count":80,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["World Neurosurgery"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.wneu.2019.08.108","type":"journal-article","created":{"date-parts":[[2019,8,27]],"date-time":"2019-08-27T11:55:12Z","timestamp":1566906912000},"page":"138-147","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Current Agents and Related Therapeutic Targets for Inflammation After Acute Traumatic Spinal Cord Injury"],"prefix":"10.1016","volume":"132","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3484-6197","authenticated-orcid":false,"given":"Ahmed","family":"Jorge","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tavis","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0256-3897","authenticated-orcid":false,"given":"Nitin","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. Kojo","family":"Hamilton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"suppl 2","key":"10.1016\/j.wneu.2019.08.108_bib1","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1227\/NEU.0b013e31827765c6","article-title":"Pharmacological therapy for acute spinal cord injury","volume":"72","author":"Hurlbert","year":"2013","journal-title":"Neurosurgery"},{"key":"10.1016\/j.wneu.2019.08.108_bib2","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.molmed.2004.10.006","article-title":"Inflammation and apoptosis: linked therapeutic targets in spinal cord injury","volume":"10","author":"Beattie","year":"2004","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.wneu.2019.08.108_bib3","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1742-2094-11-6","article-title":"Docosahexaenoic acid attenuates the early inflammatory response following spinal cord injury in mice: in-vivo and in-vitro studies","volume":"11","author":"Paterniti","year":"2014","journal-title":"J\u00a0Neuroinflammation"},{"key":"10.1016\/j.wneu.2019.08.108_bib4","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.expneurol.2007.06.009","article-title":"Inflammation and its role in neuroprotection, axonal regeneration and functional recovery after spinal cord injury","volume":"209","author":"Donnelly","year":"2008","journal-title":"Exp Neurol"},{"key":"10.1016\/j.wneu.2019.08.108_bib5","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.bbi.2009.11.007","article-title":"Astrocytes initiate inflammation in the injured mouse spinal cord by promoting the entry of neutrophils and inflammatory monocytes in an IL-1 receptor\/MyD88-dependent fashion","volume":"24","author":"Pineau","year":"2010","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.wneu.2019.08.108_bib6","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1002\/ana.10519","article-title":"Interleukin-1beta promotes oligodendrocyte death through glutamate excitotoxicity","volume":"53","author":"Takahashi","year":"2003","journal-title":"Ann Neurol"},{"key":"10.1016\/j.wneu.2019.08.108_bib7","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1523\/JNEUROSCI.4486-04.2005","article-title":"Differential regulation of AMPA receptor and GABA receptor trafficking by tumor necrosis factor-alpha","volume":"25","author":"Stellwagen","year":"2005","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.wneu.2019.08.108_bib8","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3389\/fnmol.2018.00101","article-title":"Role of caspase-8 and Fas in cell death after spinal cord injury","volume":"11","author":"Sobrido-Camean","year":"2018","journal-title":"Front Mol Neurosci"},{"key":"10.1016\/j.wneu.2019.08.108_bib9","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1007\/s00401-011-0882-3","article-title":"Fas\/FasL-mediated apoptosis and inflammation are key features of acute human spinal cord injury: implications for translational, clinical application","volume":"122","author":"Yu","year":"2011","journal-title":"Acta Neuropathol"},{"issue":"Pt 5","key":"10.1016\/j.wneu.2019.08.108_bib10","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1093\/brain\/awr054","article-title":"Human neuropathological and animal model evidence supporting a role for Fas-mediated apoptosis and inflammation in cervical spondylotic myelopathy","volume":"134","author":"Yu","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.wneu.2019.08.108_bib11","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3340\/jkns.2015.57.2.73","article-title":"Effects of tumor necrosis factor alpha blocker adalimumab in experimental spinal cord injury","volume":"57","author":"Borcek","year":"2015","journal-title":"J\u00a0Korean Neurosurg Soc"},{"key":"10.1016\/j.wneu.2019.08.108_bib12","first-page":"622","article-title":"The biochemical, histopathological and clinical comparison of the neuroprotective effects of subcutaneous adalimumab and intravenous methylprednisolone in an experimental compressive spinal cord trauma model","volume":"26","author":"Celik","year":"2016","journal-title":"Turk Neurosurg"},{"key":"10.1016\/j.wneu.2019.08.108_bib13","first-page":"771","article-title":"[Role of tumor necrosis factor-alpha in spinal cord injury of rabbits with decompression sickness]","volume":"33","author":"Wang","year":"2015","journal-title":"Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi"},{"key":"10.1016\/j.wneu.2019.08.108_bib14","doi-asserted-by":"crossref","first-page":"E861","DOI":"10.1097\/BRS.0b013e318294892c","article-title":"Effect of infliximab combined with methylprednisolone on expressions of NF-kappaB, TRADD, and FADD in rat acute spinal cord injury","volume":"38","author":"Chengke","year":"2013","journal-title":"Spine (Phila Pa 1976)"},{"key":"10.1016\/j.wneu.2019.08.108_bib15","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.surneu.2008.01.038","article-title":"Neuroprotective effects of infliximab in experimental spinal cord injury","volume":"71","author":"Kurt","year":"2009","journal-title":"Surg Neurol"},{"key":"10.1016\/j.wneu.2019.08.108_bib16","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1016\/j.jocn.2010.04.027","article-title":"Neuroprotective effects of infliximab in experimental spinal cord ischemic injury","volume":"17","author":"Guven","year":"2010","journal-title":"J\u00a0Clin Neurosci"},{"key":"10.1016\/j.wneu.2019.08.108_bib17","first-page":"375","article-title":"Neuroprotective effect of N-acetylcysteine and hypothermia on the spinal cord ischemia-reperfusion injury","volume":"11","author":"Cakir","year":"2003","journal-title":"Cardiovasc Surg"},{"key":"10.1016\/j.wneu.2019.08.108_bib18","doi-asserted-by":"crossref","first-page":"311","DOI":"10.3171\/spi.2004.1.3.0311","article-title":"Inhibition of the nuclear factor-kappaB activation with pyrrolidine dithiocarbamate attenuating inflammation and oxidative stress after experimental spinal cord trauma in rats","volume":"1","author":"La Rosa","year":"2004","journal-title":"J\u00a0Neurosurg Spine"},{"key":"10.1016\/j.wneu.2019.08.108_bib19","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/j.1471-4159.2006.04354.x","article-title":"Post-trauma Lipitor treatment prevents endothelial dysfunction, facilitates neuroprotection, and promotes locomotor recovery following spinal cord injury","volume":"101","author":"Pannu","year":"2007","journal-title":"J\u00a0Neurochem"},{"key":"10.1016\/j.wneu.2019.08.108_bib20","doi-asserted-by":"crossref","first-page":"12270","DOI":"10.3390\/ijms150712270","article-title":"Chrysin suppressed inflammatory responses and the inducible nitric oxide synthase pathway after spinal cord injury in rats","volume":"15","author":"Jiang","year":"2014","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.wneu.2019.08.108_bib21","first-page":"1337","article-title":"Hyperbaric oxygen therapy provides neuroprotection following spinal cord injury in a rat model","volume":"6","author":"Huang","year":"2013","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1016\/j.wneu.2019.08.108_bib22","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1089\/neu.2012.2371","article-title":"Acute molecular perturbation of inducible nitric oxide synthase with an antisense approach enhances neuronal preservation and functional recovery after contusive spinal cord injury","volume":"29","author":"Maggio","year":"2012","journal-title":"J\u00a0Neurotrauma"},{"key":"10.1016\/j.wneu.2019.08.108_bib23","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1089\/089771501750451857","article-title":"IL-1 receptor antagonist prevents apoptosis and caspase-3 activation after spinal cord injury","volume":"18","author":"Nesic","year":"2001","journal-title":"J\u00a0Neurotrauma"},{"key":"10.1016\/j.wneu.2019.08.108_bib24","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s12035-018-0994-z","article-title":"Ursodeoxycholic acid inhibits inflammatory responses and promotes functional recovery after spinal cord injury in rats","volume":"56","author":"Ko","year":"2019","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.wneu.2019.08.108_bib25","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1124\/jpet.111.191239","article-title":"Effect of fasudil, a selective inhibitor of Rho kinase activity, in the secondary injury associated with the experimental model of spinal cord trauma","volume":"343","author":"Impellizzeri","year":"2012","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.wneu.2019.08.108_bib26","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.neulet.2009.01.062","article-title":"Atorvastatin prevents early apoptosis after thoracic spinal cord contusion injury and promotes locomotion recovery","volume":"453","author":"Dery","year":"2009","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.wneu.2019.08.108_bib27","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1007\/s11940-014-0334-1","article-title":"Management of acute traumatic spinal cord injury","volume":"17","author":"Grant","year":"2015","journal-title":"Curr Treat Options Neurol"},{"key":"10.1016\/j.wneu.2019.08.108_bib28","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1227\/00006123-199408000-00009","article-title":"The effectiveness of surgery on the treatment of acute spinal cord injury and its relation to pharmacological treatment","volume":"35","author":"Duh","year":"1994","journal-title":"Neurosurgery"},{"key":"10.1016\/j.wneu.2019.08.108_bib29","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1080\/10790268.2007.11753918","article-title":"Spinal cord injury\u2014past, present, and future","volume":"30","author":"Donovan","year":"2016","journal-title":"J\u00a0Spinal Cord Med"},{"key":"10.1016\/j.wneu.2019.08.108_bib30","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1089\/08977150360547116","article-title":"Increased production of tumor necrosis factor-alpha induces apoptosis after traumatic spinal cord injury in rats","volume":"20","author":"Yune","year":"2003","journal-title":"J\u00a0Neurotrauma"},{"key":"10.1016\/j.wneu.2019.08.108_bib31","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1097\/00007632-200405010-00004","article-title":"Early expression and cellular localization of proinflammatory cytokines interleukin-1beta, interleukin-6, and tumor necrosis factor-alpha in human traumatic spinal cord injury","volume":"29","author":"Yang","year":"2004","journal-title":"Spine (Phila Pa 1976)"},{"key":"10.1016\/j.wneu.2019.08.108_bib32","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/S0014-4886(03)00135-3","article-title":"Expression of the type 1 and type 2 receptors for tumor necrosis factor after traumatic spinal cord injury in adult rats","volume":"183","author":"Yan","year":"2003","journal-title":"Exp Neurol"},{"key":"10.1016\/j.wneu.2019.08.108_bib33","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1002\/ana.20855","article-title":"Tumor necrosis factor-alpha contributes to below-level neuropathic pain after spinal cord injury","volume":"59","author":"Peng","year":"2006","journal-title":"Ann Neurol"},{"key":"10.1016\/j.wneu.2019.08.108_bib34","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1016\/j.pain.2014.08.034","article-title":"Peripheral noxious stimulation reduces withdrawal threshold to mechanical stimuli after spinal cord injury: role of tumor necrosis factor alpha and apoptosis","volume":"155","author":"Garraway","year":"2014","journal-title":"Pain"},{"key":"10.1016\/j.wneu.2019.08.108_bib35","doi-asserted-by":"crossref","first-page":"11391","DOI":"10.1523\/JNEUROSCI.3708-08.2008","article-title":"Cell death after spinal cord injury is exacerbated by rapid TNF alpha-induced trafficking of GluR2-lacking AMPARs to the plasma membrane","volume":"28","author":"Ferguson","year":"2008","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.wneu.2019.08.108_bib36","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.neulet.2008.04.043","article-title":"The dual role of tumor necrosis factor-alpha in the pathophysiology of spinal cord injury","volume":"438","author":"Chi","year":"2008","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.wneu.2019.08.108_bib37","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1038\/sc.2015.28","article-title":"A\u00a0pilot study on temporal changes in IL-1beta and TNF-alpha serum levels after spinal cord injury: the serum level of TNF-alpha in acute SCI patients as a possible marker for neurological remission","volume":"53","author":"Biglari","year":"2015","journal-title":"Spinal Cord"},{"key":"10.1016\/j.wneu.2019.08.108_bib38","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1124\/jpet.105.097188","article-title":"Immunomodulatory effects of etanercept in an experimental model of spinal cord injury","volume":"316","author":"Genovese","year":"2006","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.wneu.2019.08.108_bib39","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1097\/01.BRS.0000058944.38900.CE","article-title":"Tumor necrosis factor-alpha monoclonal antibody, infliximab, used to manage severe sciatica","volume":"28","author":"Karppinen","year":"2003","journal-title":"Spine (Phila Pa 1976)"},{"key":"10.1016\/j.wneu.2019.08.108_bib40","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1177\/039463201302600123","article-title":"Melkersson-Rosenthal syndrome in a patient with psoriatic arthritis receiving etanercept","volume":"26","author":"Gaudio","year":"2013","journal-title":"Int J Immunopathol Pharmacol"},{"key":"10.1016\/j.wneu.2019.08.108_bib41","doi-asserted-by":"crossref","first-page":"936","DOI":"10.3109\/00207454.2014.980906","article-title":"Soluble or soluble\/membrane TNF-alpha inhibitors protect the brain from focal ischemic injury in rats","volume":"125","author":"Arango-Davila","year":"2015","journal-title":"Int J Neurosci"},{"key":"10.1016\/j.wneu.2019.08.108_bib42","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1002\/jnr.23432","article-title":"Tumor necrosis factor-alpha inhibitors alleviation of experimentally induced neuropathic pain is associated with modulation of TNF receptor expression","volume":"92","author":"Andrade","year":"2014","journal-title":"J\u00a0Neurosci Res"},{"key":"10.1016\/j.wneu.2019.08.108_bib43","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.brainres.2014.05.038","article-title":"Early administration of tumor necrosis factor-alpha antagonist promotes survival of transplanted neural stem cells and axon myelination after spinal cord injury in rats","volume":"1575","author":"Wang","year":"2014","journal-title":"Brain Res"},{"key":"10.1016\/j.wneu.2019.08.108_bib44","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.wneu.2010.04.008","article-title":"Neuroprotective effects of gabapentin in experimental spinal cord injury","volume":"73","author":"Emmez","year":"2010","journal-title":"World Neurosurg"},{"key":"10.1016\/j.wneu.2019.08.108_bib45","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1007\/s12031-013-0083-8","article-title":"The protective effect of salvianolic acid B on blood-spinal cord barrier after compression spinal cord injury in rats","volume":"51","author":"Fan","year":"2013","journal-title":"J\u00a0Mol Neurosci"},{"key":"10.1016\/j.wneu.2019.08.108_bib46","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S0379-0738(01)00537-0","article-title":"Induction of nitric oxide synthase by traumatic brain injury","volume":"123","author":"Orihara","year":"2001","journal-title":"Forensic Sci Int"},{"key":"10.1016\/j.wneu.2019.08.108_bib47","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.neuint.2006.04.010","article-title":"Pharmacological strategies for the regulation of inducible nitric oxide synthase: neurodegenerative versus neuroprotective mechanisms","volume":"49","author":"Pannu","year":"2006","journal-title":"Neurochem Int"},{"key":"10.1016\/j.wneu.2019.08.108_bib48","first-page":"337","article-title":"Systemic administration of atorvastatin improves locomotor functions and hyperacute-acute response after experimental spinal cord injury: an ultrastructural and biochemical analysis","volume":"24","author":"Nacar","year":"2014","journal-title":"Turk Neurosurg"},{"key":"10.1016\/j.wneu.2019.08.108_bib49","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/sc.2015.180","article-title":"Mortality benefit of statin use in traumatic spinal cord injury: a retrospective analysis","volume":"54","author":"Stillman","year":"2016","journal-title":"Spinal Cord"},{"key":"10.1016\/j.wneu.2019.08.108_bib50","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1002\/jnr.22771","article-title":"Immunization with A91 peptide or copolymer-1 reduces the production of nitric oxide and inducible nitric oxide synthase gene expression after spinal cord injury","volume":"90","author":"Garcia","year":"2012","journal-title":"J\u00a0Neurosci Res"},{"key":"10.1016\/j.wneu.2019.08.108_bib51","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.bbrc.2015.10.007","article-title":"PERK pathway is involved in oxygen-glucose-serum deprivation-induced NF-kB activation via ROS generation in spinal cord astrocytes","volume":"467","author":"Liu","year":"2015","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.wneu.2019.08.108_bib52","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0304-3940(00)01167-8","article-title":"Activation of nuclear factor-kB in the spinal cord of experimental allergic encephalomyelitis","volume":"287","author":"Pahan","year":"2000","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.wneu.2019.08.108_bib53","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1007\/s10072-014-1828-z","article-title":"Tamoxifen reduces infiltration of inflammatory cells, apoptosis and inhibits IKK\/NF-kB pathway after spinal cord injury in rats","volume":"35","author":"Wei","year":"2014","journal-title":"Neurol Sci"},{"key":"10.1016\/j.wneu.2019.08.108_bib54","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0169-328X(98)00142-9","article-title":"Methylprednisolone inhibition of TNF-alpha expression and NF-kB activation after spinal cord injury in rats","volume":"59","author":"Xu","year":"1998","journal-title":"Brain Res Mol Brain Res"},{"key":"10.1016\/j.wneu.2019.08.108_bib55","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.expneurol.2014.04.006","article-title":"Cytokine pathways regulating glial and leukocyte function after spinal cord and peripheral nerve injury","volume":"258","author":"Bastien","year":"2014","journal-title":"Exp Neurol"},{"key":"10.1016\/j.wneu.2019.08.108_bib56","doi-asserted-by":"crossref","first-page":"6540","DOI":"10.1523\/JNEUROSCI.5087-12.2013","article-title":"Induction of thermal hyperalgesia and synaptic long-term potentiation in the spinal cord lamina I by TNF-alpha and IL-1beta is mediated by glial cells","volume":"33","author":"Gruber-Schoffnegger","year":"2013","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.wneu.2019.08.108_bib57","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1186\/1742-2094-9-217","article-title":"IL-1 signal affects both protection and pathogenesis of virus-induced chronic CNS demyelinating disease","volume":"9","author":"Kim","year":"2012","journal-title":"J\u00a0Neuroinflammation"},{"key":"10.1016\/j.wneu.2019.08.108_bib58","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.ejphar.2015.05.058","article-title":"IL-1 receptor antagonist improves morphine and buprenorphine efficacy in a rat neuropathic pain model","volume":"764","author":"Pilat","year":"2015","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.wneu.2019.08.108_bib59","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1152\/jn.00936.2016","article-title":"IL-1beta-induces NF-kappaB and upregulates microRNA-372 to inhibit spinal cord injury recovery","volume":"117","author":"Zhou","year":"2017","journal-title":"J\u00a0Neurophysiol"},{"key":"10.1016\/j.wneu.2019.08.108_bib60","first-page":"3","article-title":"Canakinumab","volume":"2","author":"Dhimolea","year":"2010","journal-title":"Landes Biosci"},{"key":"10.1016\/j.wneu.2019.08.108_bib61","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1111\/jnc.12286","article-title":"P2X7 receptor-induced death of motor neurons by a peroxynitrite\/FAS-dependent pathway","volume":"126","author":"Gandelman","year":"2013","journal-title":"J\u00a0Neurochem"},{"key":"10.1016\/j.wneu.2019.08.108_bib62","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s11064-010-0357-2","article-title":"Fas and FasL expression in the spinal cord following cord hemisection in the monkey","volume":"36","author":"Jia","year":"2011","journal-title":"Neurochem Res"},{"key":"10.1016\/j.wneu.2019.08.108_bib63","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1089\/neu.2011.2005","article-title":"The delayed post-injury administration of soluble fas receptor attenuates post-traumatic neural degeneration and enhances functional recovery after traumatic cervical spinal cord injury","volume":"29","author":"Robins-Steele","year":"2012","journal-title":"J\u00a0Neurotrauma"},{"key":"10.1016\/j.wneu.2019.08.108_bib64","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/sc.2012.139","article-title":"Increase in soluble CD95L during subacute phases after human spinal cord injury: a potential therapeutic target","volume":"51","author":"Biglari","year":"2013","journal-title":"Spinal Cord"},{"key":"10.1016\/j.wneu.2019.08.108_bib65","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/1440-1681.12345","article-title":"Carvedilol promotes neurological function, reduces bone loss and attenuates cell damage after acute spinal cord injury in rats","volume":"42","author":"Liu","year":"2015","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.wneu.2019.08.108_bib66","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1089\/neu.2011.2141","article-title":"Docosahexaenoic acid pretreatment confers protection and functional improvements after acute spinal cord injury in adult rats","volume":"29","author":"Figueroa","year":"2012","journal-title":"J\u00a0Neurotrauma"},{"key":"10.1016\/j.wneu.2019.08.108_bib67","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1089\/neu.2012.2718","article-title":"Dietary omega-3 polyunsaturated fatty acids improve the neurolipidome and restore the DHA status while promoting functional recovery after experimental spinal cord injury","volume":"30","author":"Figueroa","year":"2013","journal-title":"J\u00a0Neurotrauma"},{"key":"10.1016\/j.wneu.2019.08.108_bib68","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1111\/j.1471-4159.2012.07726.x","article-title":"Docosahexaenoic acid, but not eicosapentaenoic acid, reduces the early inflammatory response following compression spinal cord injury in the rat","volume":"121","author":"Hall","year":"2012","journal-title":"J\u00a0Neurochem"},{"key":"10.1016\/j.wneu.2019.08.108_bib69","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.expneurol.2012.09.015","article-title":"Improved outcome after spinal cord compression injury in mice treated with docosahexaenoic acid","volume":"239","author":"Lim","year":"2013","journal-title":"Exp Neurol"},{"key":"10.1016\/j.wneu.2019.08.108_bib70","first-page":"22","article-title":"Docosahexaenoic acid (DHA) injection in spinal cord transection stimulates Na(+),K(+)-ATPase in skeletal muscle via beta 1 subunit","volume":"60","author":"Maixent","year":"2014","journal-title":"Cell Mol Biol"},{"key":"10.1016\/j.wneu.2019.08.108_bib71","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1179\/2045772314Y.0000000251","article-title":"Omega-3 fatty acids\u2019 effect on leptin and adiponectin concentrations in patients with spinal cord injury: a double-blinded randomized clinical trial","volume":"38","author":"Sabour","year":"2015","journal-title":"J\u00a0Spinal Cord Med"},{"key":"10.1016\/j.wneu.2019.08.108_bib72","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.expneurol.2013.08.008","article-title":"Do omega-3 polyunsaturated fatty acids ameliorate spinal cord injury? Commentary on: Lim et\u00a0al., Improved outcome after spinal cord compression injury in mice treated with docosahexaeonic acid. Exp. Neurol. Jan; 239:13-27","volume":"249","author":"Satkunendrarajah","year":"2013","journal-title":"Exp Neurol"},{"key":"10.1016\/j.wneu.2019.08.108_bib73","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1742-7843.2006.pto_457.x","article-title":"Different patterns of spinal cyclooxygenase-1 and cyclooxygenase-2 mRNA expression in inflammatory and postoperative pain","volume":"99","author":"Prochazkova","year":"2006","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"10.1016\/j.wneu.2019.08.108_bib74","doi-asserted-by":"crossref","first-page":"3415","DOI":"10.1093\/hmg\/ddt191","article-title":"Celecoxib increases SMN and survival in a severe spinal muscular atrophy mouse model via p38 pathway activation","volume":"22","author":"Farooq","year":"2013","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.wneu.2019.08.108_bib75","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.4103\/1673-5374.170314","article-title":"Combination of fasudil and celecoxib promotes the recovery of injured spinal cord in rats better than celecoxib or fasudil alone","volume":"10","author":"Hou","year":"2015","journal-title":"Neural Regen Res"},{"key":"10.1016\/j.wneu.2019.08.108_bib76","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.expneurol.2014.02.025","article-title":"Changes in NG2 cells and oligodendrocytes in a new model of intraspinal hemorrhage","volume":"255","author":"Sahinkaya","year":"2014","journal-title":"Exp Neurol"},{"key":"10.1016\/j.wneu.2019.08.108_bib77","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/1742-2094-10-133","article-title":"ADAMTS proteoglycanases in the physiological and pathological central nervous system","volume":"10","author":"Lemarchant","year":"2013","journal-title":"J\u00a0Neuroinflammation"},{"key":"10.1016\/j.wneu.2019.08.108_bib78","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s00281-011-0290-8","article-title":"Fibrinogen as a key regulator of inflammation in disease","volume":"34","author":"Davalos","year":"2012","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.wneu.2019.08.108_bib79","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s13311-011-0036-2","article-title":"Novel neuroinflammatory targets in the chronically injured spinal cord","volume":"8","author":"Pajoohesh-Ganji","year":"2011","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.wneu.2019.08.108_bib80","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.nurt.2008.10.038","article-title":"Metabotropic glutamate receptors as targets for multipotential treatment of neurological disorders","volume":"6","author":"Byrnes","year":"2009","journal-title":"Neurotherapeutics"}],"container-title":["World Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878875019322648?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878875019322648?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T08:31:22Z","timestamp":1761813082000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878875019322648"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":80,"alternative-id":["S1878875019322648"],"URL":"https:\/\/doi.org\/10.1016\/j.wneu.2019.08.108","relation":{},"ISSN":["1878-8750"],"issn-type":[{"value":"1878-8750","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Current Agents and Related Therapeutic Targets for Inflammation After Acute Traumatic Spinal Cord Injury","name":"articletitle","label":"Article Title"},{"value":"World Neurosurgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.wneu.2019.08.108","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}